Oligonucleotide Synthesis Market Share,Growth, Competition, Key Players, Demand and Opportunity 2022-2027

According to IMARC Group's latest report, titled "Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global oligonucleotide synthesis market reached a value of US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2027, exhibiting a CAGR of 12.71% during 2022-2027.

Oligonucleotide synthesis is the chemical synthesis of little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. It is used in laboratories for diagnostics, academic, industrial, and therapeutic applications. Oligonucleotide synthesis helps in building monoclonal antibody primers and probes in recombinant deoxyribonucleic acid (DNA) technologies. It is majorly utilized in medical, biological, forensic, and clinical applications for gene cloning, expression, molecular diagnostics and genetic disease screening.

Request for a PDF sample of this report: https://www.imarcgroup.com/oligonucleotide-synthesis-market/requestsample

Oligonucleotide Synthesis Market Trends:

The rapid spread of coronavirus disease (COVID-19) has led to the emergent need for a potential treatment, including DNA and Ribonucleic acid (RNA) vaccines. This represents one of the primary factors driving the global oligonucleotide synthesis market toward growth. In line with this, an increasing focus on providing personalized medical care is contributing to the market growth. The rising prevalence of cancer and other chronic illnesses has positively influenced the demand for novel diagnostics, which is acting as another major growth-inducing factor. Increasing investments by governments of various nations in the research and development (R&D) of advanced genomic technologies are further creating a positive outlook for the market.

Oligonucleotide Synthesis Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global oligonucleotide synthesis market has also been examined along with the profiles of the key players.

Some of these key players include:

Agilent Technologies Inc.
Biolegio B.V.
Bio-Synthesis Inc
Eurofins Genomics
GenScript
Horizon Discovery Ltd
Integrated DNA Technologies Inc (Danaher Corporation)
Kaneka Eurogentec S.A. (Kaneka Corporation)
LGC Limited
Nitto Denko Avecia Inc (Nitto Denko Corporation)
Thermo Fisher Scientific Inc.

Key Market Segmentation:

The report has segmented the oligonucleotide synthesis market based on product, application, end use and region.

Breakup by Product:

Synthesized Oligonucleotide Products
Reagents
Equipment
Services

Breakup by Application:
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence In-Situ Hybridization (FISH)
Antisense Oligonucleotides
Others

Breakup by End Use:
Pharmaceutical and Biotechnology Companies
Hospital and Diagnostic Laboratories
Academic Research Institutes

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3812&flag=C

Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Bioinformatics Market: https://bit.ly/3ErK2th

Oncology Active Pharmaceutical Ingredients
Market: https://bit.ly/3fUc5HE

Surgical Microscopes Market: https://bit.ly/3SWuiDi

Defibrillators Market: https://bit.ly/3Vgz0gI

Digital Health Market: https://bit.ly/3CoKjKP

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.